Latest Period
n/a
Security Snapshot
Aprea Therapeutics, Inc. - Common Stock, par value $0.001 per share (APRE) Institutional Ownership
CUSIP: 03836J102
13F Institutional Holders and Ownership History from Q4 2019 to Q4 2024
Institutions Reporting
Shares (Excl. Options)
Price
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- APRE on Nasdaq
- Shares outstanding
- 228,836,687
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- APRE - Aprea Therapeutics, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 03836J102.
- Latest finished 13F holder period is not available.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 1 to 0 between Q3 2024 and Q4 2024.
- SEC-reported value moved from $2,000 to $0.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
03836J102
Latest holder period
n/a
13F holders
13D/G owners
5
CIK / CUSIP context first
APRE full holder history
Aprea Therapeutics, Inc. SEC filings
Aprea Therapeutics, Inc. company facts
Aprea Therapeutics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 03836J102:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
APRE
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Vestal Point Capital, LP | 9.9% | 22,654,832 | Vestal Point Capital, LP | 31 Mar 2026 | ||||
| Squadron Capital Management LLC | 9.9% | 1,271,081 | Squadron Master Fund LP | 30 Mar 2026 | ||||
| Soleus Private Equity Fund III, L.P. | 10% | 1,271,080 | Soleus Private Equity Fund III, L.P. | 01 Apr 2026 | ||||
| HIRSCHMAN ORIN | 9.9% | 0% | 1,186,294 | +82% | Orin Hirschman | 31 Mar 2026 | ||
| Sio Capital Management, LLC | 5.1% | $138,302 | 276,603 | Sio Capital Management, LLC | 31 Dec 2024 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
21
Latest
n/a
Rows shown
1-21 of 21
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2024 Q4 | 0 | $0 | -$2,000 | 0 | |
| 2024 Q3 | 899 | $2,000 | $2.22 | 1 | |
| 2024 Q2 | 899 | $3,000 | -$669 | $3.34 | 1 |
| 2024 Q1 | 999 | $6,669 | +$6,000 | $6.68 | 2 |
| 2023 Q4 | 100 | $470 | $4.70 | 1 | |
| 2023 Q3 | 100 | $417 | $4.17 | 1 | |
| 2023 Q2 | 100 | $315 | -$13 | $3.15 | 1 |
| 2023 Q1 | 103 | $457 | -$520,123 | $4.39 | 2 |
| 2022 Q4 | 1,587,074 | $520,280 | -$37,678 | $0.33 | 23 |
| 2022 Q3 | 1,704,277 | $1,109,338 | -$364,998 | $0.65 | 23 |
| 2022 Q2 | 2,029,597 | $1,519,025 | -$805,646 | $0.75 | 29 |
| 2022 Q1 | 2,418,438 | $4,501,000 | -$2,768,395 | $1.86 | 38 |
| 2021 Q4 | 3,610,494 | $10,361,000 | -$8,428,012 | $2.87 | 35 |
| 2021 Q3 | 4,999,711 | $25,549,281 | -$7,565,851 | $5.11 | 37 |
| 2021 Q2 | 6,538,488 | $31,906,000 | -$12,001,808 | $4.88 | 48 |
| 2021 Q1 | 8,932,107 | $45,408,770 | -$6,611,636 | $5.10 | 64 |
| 2020 Q4 | 10,317,198 | $50,763,750 | -$96,371,442 | $4.92 | 63 |
| 2020 Q3 | 16,834,877 | $404,988,700 | +$5,638,022 | $24.06 | 65 |
| 2020 Q2 | 16,477,324 | $638,906,382 | +$117,351,300 | $38.78 | 64 |
| 2020 Q1 | 13,469,861 | $467,365,016 | +$18,770,937 | $34.76 | 50 |
| 2019 Q4 | 12,931,705 | $591,290,000 | +$460,153,003 | $45.89 | 39 |